Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,309 | -2,220 | -1,781 | -845 | -332 |
| Depreciation Amortization | 1 | 2 | 1 | 1 | 0 |
| Accounts receivable | -8 | -42 | -40 | -7 | -4 |
| Other Working Capital | 442 | -910 | -119 | -87 | -78 |
| Other Operating Activity | 50 | 150 | 219 | 150 | 20 |
| Operating Cash Flow | $-823 | $-3,020 | $-1,720 | $-789 | $-394 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -7 | -3 | -2 | 3 |
| Investing Cash Flow | $N/A | $-7 | $-3 | $-2 | $3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7 | 4,593 | 4,583 | 978 | 521 |
| Other Financing Activity | 0 | -3 | 0 | 0 | 0 |
| Financing Cash Flow | $7 | $4,590 | $4,583 | $978 | $521 |
| Exchange Rate Effect | 19 | 8 | -56 | 10 | 39 |
| Beginning Cash Position | 1,736 | 160 | 166 | 166 | 166 |
| End Cash Position | 939 | 1,730 | 2,971 | 363 | 334 |
| Net Cash Flow | $-798 | $1,570 | $2,805 | $197 | $168 |
| Free Cash Flow | |||||
| Operating Cash Flow | -823 | -3,020 | -1,720 | -789 | -394 |
| Capital Expenditure | N/A | -7 | -3 | -2 | N/A |
| Free Cash Flow | -823 | -3,027 | -1,723 | -791 | -394 |